| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |